Deals, Partnering

Romark and Chugai Pharmaceutical enter exclusive licensing deal for nitazoxanide in Japan

Posted on 18 February 2009

Tags: ,

Chugai has paid an upfront payment to Romark, and will make additional payments based on the achievement of certain clinical and regulatory milestones. Romark will participate in profits from product sales in Japan through a supply agreement and royalties.

Print Friendly, PDF & Email

Leave a Reply